Navigation Links
Summit VetPharm Introduces New Feline Topicals Vectra(TM) for Cats & Kittens and Vectra(TM) for Cats
Date:2/11/2008

First Topical Products Available that Kills Fleas in just 6 Hours

FORT LEE, N.J., Feb. 11 /PRNewswire/ -- Summit VetPharm today announced the introduction of a new flea treatment. Vectra(TM) for Cats & Kittens and Vectra(TM) for Cats feature a combination of Dinotefuran and Pyriproxyfen that delivers rapid, effective and more complete relief for cats and kittens.
(Photo: http://www.newscom.com/cgi-bin/prnh/20080211/NYM095A )

The new Vectra product:

-- Kills adult fleas within six hours.

-- Kills fleas that may transmit disease, including bartonellosis,

tapeworm and tularemia.

-- Controls the development of all flea stages: eggs, larvae and pupae for

at least one month.

-- Can be used on kittens as young as 8 weeks of age.

Dinotefuran is a novel, fast-acting third generation neonicotinoid not previously used on felines with a unique mode of action. Pyriproxifen, a superior second-generation insect growth regulator, controls the development of immature fleas and exhibits long-lasting activity on cats and kittens.

In side-by-side comparisons, Vectra outperformed the two leading feline treatments at two, six and 12 hours post treatment, in terms of adulticidal speed of kill. In flea reduction and egg hatchability studies, of the few eggs collected from Vectra-treated cats, all (100%) failed to hatch.

"Veterinarians have been waiting for a product like Vectra for Cats & Kittens and Vectra for Cats," said Dr. Albert H. Ahn, DVM, senior director of veterinary services for Summit VetPharm. "The chronic nature of flea control contributes to the potential for resistant fleas. Our feline product is a novel formulation fleas have never encountered."

Vectra is colorless, odor-free, non-greasy and quick-drying. The unique, patented applicator features an elongated tip that makes it easy to apply to a feline's skin through the haircoat. The rounded tip minimizes risk of skin abrasions. The easy-to-open applicator eliminates splash back and spilling, and the contoured shape makes it easier to handle. With the one-piece applicator, there is no need to use scissors to open or remove a cap, making application fast, efficient and easy.

"We've received rave reviews from veterinarians and pet owners about our applicator," said Ahn. "It not only makes application easier and cleaner, the applicator makes it easier to reach the cat's skin so that product is not spilled during the application."

Vectra(TM) for Cats & Kittens and Vectra for Cats are protected with Summit VetPharm's Bloodhound(TM) Technology - an innovative, proprietary track and trace system that ensures veterinary exclusivity of the product. Each package of Vectra can be traced from the point of manufacture to veterinarian purchase. Bloodhound Technology allows Summit VetPharm to maintain the integrity of its products through a secure distribution channel, as well as guarding against counterfeiting.

"By securing our supply chain, we are able to protect the veterinary professional, maintain authenticity of our products, and enhance the role of veterinarians in the lives of the animals they treat. Through our Bloodhound Technology, we can help keep companion animal health exactly where it belongs - in the hands of professionals," says Julia Stephanus, president and CEO of Summit VetPharm.

The new cat formula in the Vectra family of products is available to pet owners only through licensed veterinarians.

Vectra for Cats & Kittens is available in 3-dose and 6-dose packages: 0.8 mL for cats and kittens 8 weeks and older and less than 9 lbs. Vectra for Cats is available in 3-dose and 6-dose packages: 1.2 mL for cats weighing 9 lbs. and over.

Vectra for Cats & Kittens, Vectra for Cats and Vectra 3D for Dogs are available to veterinarians through Summit VetPharm and Abbott Animal Health sales representatives, as well as from the following distributors: Associated Medical Supply, Great Western Animal Health, Midwest Veterinary Supply, Inc., Merritt Veterinary Supplies, Inc., Henry Schein Animal Health, NLS Animal Health, Northeast Veterinary Supply Company (NEVSCO), PCI Animal Health, Sanum Puerto Rico, and Victor Medical Company.

Summit VetPharm

Founded by veterinarians and experienced industry professionals, Summit VetPharm is committed to protecting the health and welfare of both companion animals and companion animal veterinary practices. As a wholly-owned subsidiary of the Sumitomo Corporation and part of the Sumitomo Corporation group of companies, Summit VetPharm is backed by a longstanding reputation for values and ethics in business and is dedicated to raising the standards in animal health. Summit VetPharm is headquartered in Fort Lee, New Jersey, USA. For more information, visit Summit VetPharm at http://www.summitvetpharm.com


'/>"/>
SOURCE Summit VetPharm
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Cogdell Spencer Inc. Acquires Summit Professional Plaza I and II in Brunswick, Georgia
2. Cardiovascular Technologies to be Highlighted at 5th Annual Cleveland Clinic Medical Innovation Summit, Oct. 1-3
3. Education Key Focus of Michigan Policy Summit
4. Skinvisible to Present at Merriman Curhan Ford & Co.s Investor Summit 2007
5. DURECT to Present at Merriman Curhan Fords Annual Investor Summit
6. Partners Rx Chief Pharmacy Officer, Richard Bullard on Panel Discussion at the Fall 2007 Managed Markets Summit (MMS) in Phoenix, AZ.
7. Hooper Holmes Launches Health & Wellness Division at 2007 Disease Management Leadership Forum and Integrated Care Summit
8. Historic Breast Cancer Global Advocate Summit Convenes in Budapest, Hungary on September 29-30
9. Summit on Spinal Muscular Atrophy
10. Global Leaders Converge for Special Olympics Global Policy Summit
11. Sanofi-aventis US Chairman Tim Rothwell Addresses CMSAs Collaborative Practice Summit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... ... May 05, 2016 , ... A local study examining asthma ... 40 percent of participating fifth-grade students already have or are at risk for ... Research in the Division of Pulmonary, Allergy and Critical Care Medicine at ...
(Date:5/5/2016)... ... 2016 , ... Sun Health registered nurse Brittany Eads and ... Care Transitions program at the 9th Annual Orthopedic and Spine Summit held ... Post-Acute Environment Through Effective Transitions of Care.” , Major changes are taking place ...
(Date:5/5/2016)... ... (PRWEB) May 05, 2016 , ... Talent Tech Labs (TTL) ... the eve of National Nurses Week (May 6-12). Currently, HireNurses is a ... their enrollment into the Talent Tech Lab Virtual Incubation program, they will dramatically expand ...
(Date:5/5/2016)... (PRWEB) , ... May 05, 2016 , ... The Lung Institute will celebrate ... attending a seminar at most clinic locations throughout the month of May. To date, the ... , “The rapid growth that we’ve seen is a testament to the success of this ...
(Date:5/5/2016)... ... May 05, 2016 , ... With May flowers, summer is just around the corner. Summer means ... respite from school and the ability to play all day and night. Parents often lament ... watch the little tykes themselves. Summer also means trips to the beach, backyard cookouts, fireworks ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... 2016 Yissum Research Development ... today that it had signed an exclusive world-wide licensing ... of novel protein degradation and immunomodulatory drugs for cancer ... drug candidates representing first-in-class therapy for hematologic and solid ... The novel technology was developed by ...
(Date:5/4/2016)... , May 4, 2016 ... of the  "Global Acute Myeloid Leukemia Market ... to their offering.       (Logo: ... Myeloid Leukemia Market and Competitive Landscape Highlights ... Leukemia pipeline products, Acute Myeloid Leukemia epidemiology, ...
(Date:5/3/2016)... , May 4, 2016 Research ... "Global Cancer Stem Cell Therapy Market Outlook 2020" ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,Recombinant technology has improved significantly ... expected to be developed in coming years. Many cancer ... Cancer stem cell therapies are also expected to be ...
Breaking Medicine Technology: